Nanotechnology Now

Our NanoNews Digest Sponsors


Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > One on One with Investors: Pitch Strategy Discourse with Nanobiotechnology Experts

Abstract:
The Center of Innovation for Nanobiotechnolgy (COIN) announced today that they will be hosting a new offering―a private pitch and strategy coaching session with a team of seasoned investors―at the 2011 North Carolina Nanotechnology Commercialization Conference (NCNCC). Interested participants can sign up for a 30-minute slot with experts to pitch their business and technology, receiving feedback and guidance in addressing tough questions. Slots are offered to registered NCNCC attendees on the afternoon of March 29th from 2 until 5 PM. Grant Thornton LLP generously sponsored this event.

One on One with Investors: Pitch Strategy Discourse with Nanobiotechnology Experts

Durham, NC | Posted on March 16th, 2011

This offering is part of NCNCC, a day-and-a-half conference that is organized by NC Commerce, is in its 3rd year and typically draws approximately 300+ leading nanobiotech and nanotech experts from industry and academia to address key commercialization issues. Nanomedicine entrepreneurs face significant challenges in building their business and developing inventions into marketable platform technology or products. This new dedicated "One on One with Investors: Pitch Strategy Discourse with Experts" offering will be a significant value-add for the conference, helping companies overcome stumbling blocks before they approach investors.



"No entrepreneur wants to be stuck in the starting gate simply because potential customers don't understand or value their product," said John Hardin, Executive Director of NC Commerce's Office of Science and Technology. "Discourse like what these sessions will offer is critical for helping entrepreneurs understand what appeals to the market and how best to position their products to maximize sales. I expect many of the entrepreneurs will consider these sessions to be some of the most valuable 30 minutes they spend in the course of taking their product to market."

COIN is working with NC Commerce to increase the nanomedicine track of the NCNCC, and this "One on One with Investors: Pitch Strategy Discourse with Experts" offering will be one of several new elements that will debut at the 2011 conference. In addition to the pitch sessions, COIN will offer an add-on workshop the morning of March 29th titled: "Actionable Strategies for Company Building and Moving to Market."



Pitch sessions will be held March 29, 2011 from 2-5 PM. This offering is open to any registered attendee of NCNCC. The pitch room is for all NCNCC attendees, not just nanobio/nanomedicine participants. Conference attendees can sign up for a 30-minute slot with experts to make their funding presentation detailing their company or new venture's business and technology and receive feedback and help answering the tough questions. Participating experts include: Bill Warner from Paladin Associates, Nick Wachtel from Lux Capital, Mike Elliot from Noro Moseley, Joe Velk from Contender Capital and Rob Tyler of Poyner Spruill. The cost to participants is included in NCNCC registration. To reserve these coveted spaces, please email: with the title "NCNCC One on One Request".

####

For more information, please click here

Contacts:
Dr. Laura Faulconer

Director, Innovation Projects

The Venable Center, 303 South Roxboro St., Suite 30

Durham, NC 27701



Office: (919) 680-2070 ext 301

Copyright © The Center of Innovation for Nanobiotechnolgy (COIN)

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Personal cooling units on the horizon April 29th, 2016

Exploring phosphorene, a promising new material April 29th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

The Translational Research Center at the University Hospital of Erlangen in Germany uses the ZetaView from Particle Metrix to quantify extracellular vesicles such as exosomes April 28th, 2016

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

ORIG3N Added to Companies Presenting at Harris & Harris Group's Annual Meeting, Tuesday June 7, 2016, the New York Genome Center April 27th, 2016

Philadelphia Mathematician Robert Clark Turns to Crowdfunding to Support Nanotechnology Research That Could Lead to ‘Flying’ Cars and Space Elevator April 4th, 2016

Harris & Harris Group Announces Formation of Co-Investment Fund for Accredited Investors March 9th, 2016

Clinatec Announces €30M Fundraising Campaign to Speed Research In Treatment of Neurodegenerative Diseases, Cancer and Motor Disabilities February 24th, 2016

Announcements

Personal cooling units on the horizon April 29th, 2016

Exploring phosphorene, a promising new material April 29th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

The Translational Research Center at the University Hospital of Erlangen in Germany uses the ZetaView from Particle Metrix to quantify extracellular vesicles such as exosomes April 28th, 2016

Events/Classes

Researchers create a first frequency comb of time-bin entangled qubits: Discovery is a significant step toward multi-channel quantum communication and higher capacity quantum computers April 28th, 2016

Introducing the RE標ORK Bio-inspired Robotics Summit in Berlin April 27th, 2016

ORIG3N Added to Companies Presenting at Harris & Harris Group's Annual Meeting, Tuesday June 7, 2016, the New York Genome Center April 27th, 2016

Team builds first quantum cascade laser on silicon: Eliminates the need for an external light source for mid-infrared silicon photonic devices or photonic circuits April 21st, 2016

Nanobiotechnology

Nanoparticles hold promise as double-edged sword against genital herpes April 28th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

The Translational Research Center at the University Hospital of Erlangen in Germany uses the ZetaView from Particle Metrix to quantify extracellular vesicles such as exosomes April 28th, 2016

JPK reports on the use of a NanoWizard AFM system at the University of Kaiserslautern to study the interaction of bacteria with microstructured surfaces April 28th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic